Clinical Trials Browser

Completed × Lymphoma, B-Cell × Everolimus × Clear all

NCT01665768 2021-10-26

Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

Phase 2 Completed

56 enrolled 10 charts

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT00702052 2021-05-25

PILLAR-1

Phase 2 Completed

58 enrolled 11 charts

Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT00790036 2017-07-12

PILLAR2

Phase 3 Completed

742 enrolled 10 charts

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms